Results presented at the 2020 Infectious Diseases Society for Obstetrics & Gynecology (IDSOG) Virtual Annual Meeting Single-dose treatment with Solosec®…
Primary endpoint successfully achieved in Phase 3 clinical trial of 147 patients Solosec® 2g oral granules was generally well-tolerated among…